Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06410495 · ClinicalTrials.gov registry record · NA

Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)

A NA study of Insomnia Chronic and Oppositional Defiant Disorder, sponsored by University of South Florida.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06410495 is a NA study of Insomnia Chronic and Oppositional Defiant Disorder that is actively recruiting participants, run by University of South Florida. The registered enrollment target is 30 participants, below the 117-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06410495, a NA study of Insomnia Chronic and Oppositional Defiant Disorder, is actively recruiting participants, sponsored by University of South Florida.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.

Interventions

  • BEHAVIORAL NiteCAPP SINCC

Study Locations (1)

Florida

  • University of South Florida - Tampa

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-05-01
Est. Completion 2025-12-01
Phase NA

Sponsor

University of South Florida

252 total trials

What the Registry Record Tells You About NCT06410495

The ClinicalTrials.gov registry entry for NCT06410495 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 16 other Insomnia Chronic trials with a reported enrollment target (74% lower). The listed sponsor is University of South Florida, which has 252 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Insomnia Chronic appearing as the primary indexed condition, and to 1 intervention - of which NiteCAPP SINCC is the first listed.

NCT06410495 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT06410495 about?

NCT06410495 is a clinical study titled "Digital Dyadic Family Based Intervention to Improve Sleep in Children with ODD and Their Parents: NiteCAPP SINCC (Pilot)". In this proposal a brief web-based cognitive behavioral treatment for insomnia (CBT-I) for children with oppositional defiant disorder (ODD) and their parents is iteratively adapted and tested for acceptability, feasibility, and preliminary efficacy.

What is the current status of trial NCT06410495?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-05-01. Estimated completion is 2025-12-01.

What conditions does trial NCT06410495 study?

This clinical trial studies the following conditions: Insomnia Chronic, Oppositional Defiant Disorder.

What interventions are being tested in trial NCT06410495?

The interventions under investigation include: NiteCAPP SINCC (BEHAVIORAL).

Who is sponsoring clinical trial NCT06410495?

This trial is sponsored by University of South Florida, which has 252 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06410495 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.